Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiopoietin-2 inhibitor PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Macular Degeneration 3 D008268 ClinicalTrials
Wet Macular Degeneration 3 D057135 ClinicalTrials
Macular Degeneration 3 D008268 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1607793-29-2
ChEMBL CHEMBL4297750
FDA SRS QC4F7FKK7I